MAPK14 and lung cancer: The effect of gefitinib was investigated on the phosphorylation of EGFR, Akt, p44/42 MAP kinase, and p38 MAP kinase, in serum-starved, gefitinib-pretreated lung cancer cells (Figs. 7 and 8).